JP2021516225A5 - - Google Patents
Info
- Publication number
- JP2021516225A5 JP2021516225A5 JP2020543957A JP2020543957A JP2021516225A5 JP 2021516225 A5 JP2021516225 A5 JP 2021516225A5 JP 2020543957 A JP2020543957 A JP 2020543957A JP 2020543957 A JP2020543957 A JP 2020543957A JP 2021516225 A5 JP2021516225 A5 JP 2021516225A5
- Authority
- JP
- Japan
- Prior art keywords
- compound according
- optionally substituted
- compound
- butyl
- alkylene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023214175A JP7809096B2 (ja) | 2018-03-05 | 2023-12-19 | イミダゾジアゼピンジオン及びその使用方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862638448P | 2018-03-05 | 2018-03-05 | |
| US62/638,448 | 2018-03-05 | ||
| PCT/US2019/020732 WO2019173327A1 (en) | 2018-03-05 | 2019-03-05 | Imidazodiazepinediones and methods of use thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023214175A Division JP7809096B2 (ja) | 2018-03-05 | 2023-12-19 | イミダゾジアゼピンジオン及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021516225A JP2021516225A (ja) | 2021-07-01 |
| JP2021516225A5 true JP2021516225A5 (cg-RX-API-DMAC7.html) | 2022-03-14 |
| JP7408557B2 JP7408557B2 (ja) | 2024-01-05 |
Family
ID=67847465
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543957A Active JP7408557B2 (ja) | 2018-03-05 | 2019-03-05 | イミダゾジアゼピンジオン及びその使用方法 |
| JP2023214175A Active JP7809096B2 (ja) | 2018-03-05 | 2023-12-19 | イミダゾジアゼピンジオン及びその使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023214175A Active JP7809096B2 (ja) | 2018-03-05 | 2023-12-19 | イミダゾジアゼピンジオン及びその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US11623930B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP3761989A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7408557B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN118908961A (cg-RX-API-DMAC7.html) |
| AU (2) | AU2019231208B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3093084A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019173327A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3093084A1 (en) | 2018-03-05 | 2019-09-12 | Goldfinch Bio, Inc. | Imidazodiazepinediones and methods of use thereof |
| JP2022551580A (ja) * | 2019-10-04 | 2022-12-12 | ゴールドフィンチ バイオ，インク． | 巣状分節性糸球体硬化症および糖尿病性腎症のバイオマーカーに基づく処置 |
| CN115927202A (zh) * | 2023-01-10 | 2023-04-07 | 北京爱思益普生物科技股份有限公司 | 一种trpc5突变细胞株及其构建方法和应用 |
| WO2024153028A1 (zh) * | 2023-01-20 | 2024-07-25 | 深圳晶蛋生物医药科技有限公司 | 大环类化合物、其药物组合物及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1994020460A1 (en) * | 1993-03-11 | 1994-09-15 | Smithkline Beecham Corporation | Chemical compounds |
| WO2009086303A2 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| TW201444844A (zh) * | 2013-03-14 | 2014-12-01 | Hydra Biosciences Inc | 經取代之黃嘌呤及使用其之方法 |
| CN107082782B (zh) | 2013-03-15 | 2020-03-20 | 海德拉生物科学有限责任公司 | 取代的黄嘌呤及其使用方法 |
| JP6667092B2 (ja) | 2014-08-11 | 2020-03-18 | ハイドラ・バイオサイエンシーズ・リミテッド・ライアビリティ・カンパニーＨｙｄｒａ Ｂｉｏｓｃｉｅｎｃｅｓ， ＬＬＣ | ピロロ［３，２−ｄ］ピリミジン−２，４（３Ｈ，５Ｈ）−ジオン誘導体 |
| DK3652176T3 (da) | 2017-07-11 | 2022-01-17 | Boehringer Ingelheim Int | Substituerede xanthinderivater |
| CA3093084A1 (en) | 2018-03-05 | 2019-09-12 | Goldfinch Bio, Inc. | Imidazodiazepinediones and methods of use thereof |
| EP3917940A1 (en) * | 2019-01-30 | 2021-12-08 | Rothamsted Research Ltd | Cylodimer of dehydrosalicortin and derivatives thereof isolated from plant of the genus salix for use in cancer therapy |
-
2019
- 2019-03-05 CA CA3093084A patent/CA3093084A1/en active Pending
- 2019-03-05 EP EP19763337.3A patent/EP3761989A4/en active Pending
- 2019-03-05 CN CN202410783264.2A patent/CN118908961A/zh active Pending
- 2019-03-05 US US16/977,945 patent/US11623930B2/en active Active
- 2019-03-05 CN CN201980030356.0A patent/CN112351781B/zh active Active
- 2019-03-05 WO PCT/US2019/020732 patent/WO2019173327A1/en not_active Ceased
- 2019-03-05 JP JP2020543957A patent/JP7408557B2/ja active Active
- 2019-03-05 AU AU2019231208A patent/AU2019231208B2/en active Active
-
2023
- 2023-02-01 US US18/104,610 patent/US12466834B2/en active Active
- 2023-12-19 JP JP2023214175A patent/JP7809096B2/ja active Active
-
2025
- 2025-04-17 AU AU2025202716A patent/AU2025202716A1/en active Pending